///issues/news//122292-1.html"NEW YORK, Sept. 8 (GenomeWeb News) - Expression Analysis said today that it has submitted to the FDA a mock submission of microarray data for use by the agency in its development of guidance on the format, content, and context of such data in regulatory submissions.

As previously reported in BioArray News, the FDA is in the process of drafting a framework for the standardized submission of gene expression data in the regulatory process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.